World of DTC Marketing

JANUARY 1, 2022

More and more patients demand a level of service they want with the increased costs of health insurance premiums. 1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections.

Healthcare 244

Healthcare Healthcare Side effects Prescription 244

Pharmaceutical Technology

MAY 25, 2023

Pushing back an initial deadline, the US Food and Drug Administration (FDA) has proposed a new regulatory action date of 22 June, by which time the agency will assess the logistics of a possible approval for Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) gene therapy.

FDA 52

FDA Food and Drug Administration Prescription Food 52

pharmaphorum

SEPTEMBER 26, 2022

Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D). Still to come, of course, will be the challenges of ensuring access and reimbursement for the DTx, if approved by the FDA.

FDA 52

FDA Prescription Patients Medical 52

World of DTC Marketing

MARCH 11, 2022

Most patients completely trusted their physicians “to put their needs above all other considerations” (69%). According to Accenture, “the pharma industry has ‘earned’ some modest gains in trust from patients due to vaccine development. Even patients will still line up if a prescription drug shows promise.

Physicians 212

Physicians Healthcare Healthcare Prescription 212

Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Pharmacology Side effects 98

Pharmaceutical Technology

AUGUST 12, 2022

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The FDA’s action plan. The first AdCom was critical of the study’s robustness.

FDA 98

FDA Food and Drug Administration Physicians Side effects 98

Clarify Health

MAY 11, 2022

Pfizer partnered with Clarify Health for a real-world study assessing medication adherence to tafamidis among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study found that real-world adherence to tafamidis in patients with ATTR-CM was high.

Medical 52

Medical Patients Prescription FDA 52

World of DTC Marketing

JUNE 22, 2022

A new feature—a sensor that monitors changes in the heart rate for irregularities that can lead to strokes and heart failure—has just been approved by America’s Food and Drug Administration (FDA). The FDA’s stamp of approval for the Fitbit sensor is a big deal. Google is also giving health records another whirl.

Healthcare 227

Healthcare Healthcare Food and Drug Administration FDA 227

World of DTC Marketing

NOVEMBER 18, 2021

I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.

Pharma 202

Pharma Prescription Medicine Manufacturing 202

Legacy MEDSearch

MARCH 15, 2023

The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product. Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring.

Food and Drug Administration 97

Food and Drug Administration FDA Recruitment Physicians 97

Legacy MEDSearch

JULY 6, 2023

Food and Drug Administration (FDA). The InTandem name reflects both the synchronization inherent in the device’s mechanism of action and the partnership formed between patient and device. The burden on patient functioning is also profound. MedRhythms also unveiled the brand name for MR-001: InTandem.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Clarify Health

MAY 11, 2022

Clarify Health published a real-world study assessing medication adherence among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study found that real-world adherence to the treatment in patients with ATTR-CM was high. Read the full study published in Patient Preference and Adherence.

Medical 40

Medical Patients Prescription FDA 40

Clarify Health

MAY 11, 2022

Clarify Health published a real-world study assessing medication adherence among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study found that real-world adherence to the treatment in patients with ATTR-CM was high. Read the full study published in Patient Preference and Adherence.

Medical 52

Medical Patients Prescription FDA 52

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

Legacy MEDSearch

APRIL 25, 2023

Food and Drug Administration (FDA). Paradigm utilizes an advanced approach to replace traditional surgical navigation technologies that pull attention away from the patient and disrupt workflows in the process. ABOUT PROPRIO Proprio is a leading medical technology company creating the new way of seeing in surgery.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

World of DTC Marketing

FEBRUARY 22, 2021

Jazz Pharmaceuticals has introduced a new prescription medication for patients with sleep apnea/narcolepsy that “helped adults get up to 9 hours of improved wakefulness in clinical studies at 12 weeks” and they’re using a flying pig on their DTC. This DTC is an embaressment.

Pharma 181

Pharma Doctors Side effects Prescription 181

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. This leads to a question; “where does it end?” For DTC, the model will become one of collaboration with patients as they help them navigate the complex system of American healthcare.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

Pharmaceutical Technology

FEBRUARY 13, 2023

Elyxyb is a prescription nonsteroidal anti-inflammatory drug (NSAID) used for acute migraine treatment in adult patients with or without aura. Elyxyb is claimed to be the only FDA-approved first-line treatment, ready-to-use solution of celecoxib developed for the indication.

Prescription 52

Prescription FDA Medicine Patients 52

pharmaphorum

DECEMBER 22, 2022

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. We can now measure patient activity, steps, and movement continuously and in real time, which serves as a new potential indicator of treatment effectiveness.

FDA 85

FDA Patients Electronics Medical 85

Pharmaceutical Technology

APRIL 18, 2023

Three regulators in different jurisdictions have accepted Bristol Myers Squibb’s applications for Abecma (idecabtagene vicleucel) for earlier use to treat triple-class exposed relapsed and/or refractory multiple myeloma in adult patients. Abecma treatment showed improvement in progression-free survival and overall response rate.

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Food 52

PM360

SEPTEMBER 15, 2022

For example, Lisa Harris, a professor of reproductive health at the University of Michigan wrote to The New England Journal of Medicine , “Might abortion be permissible in a patient with pulmonary hypertension, for whom we cite a 30 – 50% chance of dying with ongoing pregnancy? Or must it be 100%?”. Qualio surveyed 2,002 U.S.

Healthcare 52

Healthcare Healthcare Doctors Physicians 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

Current treatment options for DES are dominated by a mix of prescription and over-the-counter (OTC) products. Artificial tears are also used extensively in conjunction with prescription therapies for symptomatic relief. Novaliq/ Bausch + Lomb’s NOV-3 (perfluorohexyloctane) is also currently at pre-registration stage with the FDA.

Prescription 59

Prescription Physicians FDA Marketing 59

pharmaphorum

NOVEMBER 2, 2022

The struggle to manage pain for individuals has been one that goes back a long way in history, with one of the earliest recorded medical prescriptions being for opium. This leads to psychological harm becoming a significant factor in chronic pain, alongside the physical symptoms. The potential for a digital solution.

Food and Drug Administration 131

Food and Drug Administration Food FDA Patients 131

Pharmaceutical Technology

MARCH 3, 2023

Albireo’s pipeline includes its lead asset, Bylvay (odevixibat), a potent, once-a-day, oral, non-systemic, ileal bile acid transport inhibitor (IBATi). In 2021, it secured regulatory approvals in the US to treat pruritus in progressive familial intrahepatic cholestasis (PFIC) in patients aged three months and above.

Pharma 52

Pharma Food and Drug Administration Transportation Prescription 52

pharmaphorum

OCTOBER 3, 2022

Amylyx Pharmaceuticals’ Relyvrio – a new treatment for amyotrophic lateral sclerosis (ALS) approved by the FDA on Thursday, after review of the data from its phase 2 trial – was the next day set at a list price of $158,000 per year in the US, sparking outcry. It can lead to progressive paralysis and death.

Insurance 52

Insurance Prescription FDA Patients 52

pharmaphorum

AUGUST 11, 2022

More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. billion in the United States alone.

Side effects 90

Side effects Medical Prescription Patients 90

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

Clarivate

OCTOBER 30, 2022

Half of the psychiatrists surveyed reported having prescribed or recommended DTx to patients within the three studied indications, while the remainder indicated they expect or are open to prescribing them. As a result, few products have FDA clearance. Payers and providers embrace evidence-based DTx. What’s next?

Insurance 52

Insurance FDA Prescription Marketing 52

Legacy MEDSearch

OCTOBER 16, 2023

“The real-time 3D imagery allowed us to visualize the patient’s anatomy in ways not previously available to us. That will ultimately enable us to drive better outcomes for patients.” ABOUT PROPRIO Proprio is a leading medical technology company creating the new way of seeing in surgery.

Recruitment 52

Recruitment Medical Healthcare Healthcare 52

European Pharmaceutical Review

NOVEMBER 15, 2022

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.”

Manufacturing 88

Manufacturing Pharma Food and Drug Administration Safety 88

Clarify Health

OCTOBER 26, 2021

Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. In fact, 73% were White, 14% were Asian, 6% were Hispanic, and 5% were African American. However, another study found that 0.1% 2] Figure 1.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

PM360

AUGUST 9, 2022

The industry has been limited in its ability to implement creative solutions to engage and motivate patients because the FDA has strict guidelines for what pharma companies can communicate with patients. Today, we still can’t easily discern whether a patient took their pill or not and the reason why. Michael Oleksiw.

Medical 105

Medical Electronics Patients Healthcare 105

Legacy MEDSearch

OCTOBER 25, 2023

Andrea Synowiec, a neurologist and headache specialist who serves as System Vice Chair of the Department of Neurology at Allegheny Health Network in Pennsylvania is the lead author of the study. As for clinical efficacy, 74.1% of the participants reported consistent 2-hour pain relief, and 26% reported consistent pain freedom.

Side effects 52

Side effects Recruitment Networking Management 52

Silver Line CRM

NOVEMBER 11, 2020

But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. . Prescription lift. Consumerization of the patient. I know what you’re thinking: “Please, not another PowerPoint or spreadsheet.”.

Marketing 52

Marketing Pharmaceutical Side effects Insurance 52

pharmaphorum

JULY 7, 2022

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. It can lead to other health problems, including high blood pressure, heart attack, stroke and diabetes.

FDA 104

FDA Prescription Healthcare Provider Physicians 104

Contrarian Sales Techniques

DECEMBER 5, 2023

Regulation changes, like the introduction of the Prescription Drug Marketing Act in the 1980s, brought about a more structured approach. As treatments become more tailored to individual patients, sales reps must understand complex scientific concepts and communicate them effectively. But it wasn't just about being personable.

Pharmaceutical Sales 52

Pharmaceutical Sales Training Sales Pharmaceutical 52

Evolve Your Success

JANUARY 31, 2023

A lot of organizations that may have a sales model don’t probably follow the prescription that we deliver or the method that we deliver to them, which is why they contract us. From a management perspective, what happens is that you see managers who begin to believe that they can lead their team from behind their desks.

Medical sales 64

Medical sales Sales Medical Training 64